Bioceres Crop Solutions Corp.BIOXEarnings & Financial Report
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
BIOX Q1 2026 Key Financial Metrics
Revenue
$77.6M
Gross Profit
$36.3M
Operating Profit
$7.2M
Net Profit
$-7.4M
Gross Margin
46.8%
Operating Margin
9.3%
Net Margin
-9.6%
YoY Growth
-16.8%
EPS
$-0.12
Financial Flow
Bioceres Crop Solutions Corp. Q1 2026 Financial Summary
Bioceres Crop Solutions Corp. reported revenue of $77.6M (down 16.8% YoY) for Q1 2026, with a net profit of $-7.4M (down 20.2% YoY) (-9.6% margin). Cost of goods sold was $41.3M, operating expenses totaled $29.1M.
Key Financial Metrics
| Total Revenue | $77.6M |
|---|---|
| Net Profit | $-7.4M |
| Gross Margin | 46.8% |
| Operating Margin | 9.3% |
| Report Period | Q1 2026 |
Bioceres Crop Solutions Corp. Quarterly Revenue & Net Profit History
Bioceres Crop Solutions Corp. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 2026 | $77.6M | -16.8% | $-7.4M | -9.6% |
| Q3 2025 | $60.6M | -27.9% | $-1.6M | -2.6% |
| Q2 2025 | $98.8M | -29.5% | $605.2K | 0.6% |
| Q1 2025 | $93.3M | -20.0% | $-6.2M | -6.6% |
| Q3 2024 | $84.0M | -9.2% | $9.8M | 11.6% |
| Q2 2024 | $140.2M | +50.9% | $1.2M | 0.9% |
| Q1 2024 | $116.6M | -8.4% | $-2.7M | -2.3% |
| Q3 2023 | $92.5M | — | $27.5M | 29.7% |
Income Statement
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $92.5M | $116.6M | $140.2M | $84.0M | $93.3M | $98.8M | $60.6M | $77.6M |
| YoY Growth | N/A | -8.4% | 50.9% | -9.2% | -20.0% | -29.5% | -27.9% | -16.8% |
Balance Sheet
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $846.8M | $819.7M | $819.5M | $836.1M | $827.3M | $835.2M | $798.2M | $734.9M |
| Liabilities | $512.5M | $487.1M | $484.3M | $487.6M | $481.2M | $488.9M | $453.2M | $446.5M |
| Equity | $334.3M | $332.6M | $335.3M | $348.5M | $346.0M | $346.3M | $345.0M | $288.3M |
Cash Flow
| Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $2.2M | $14.7M | $21.1M | $-17.4M | $5.2M | $-5.4M | $23.3M | $14.4M |